Purchase Order HHSN269201700584P
- Not listed
- This is a firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Miltenyi Biotec, Inc., a global biotechnology company that provides specialized scientific instruments, reagents, and services for biomedical research and cell therapy development. The $7,009 contract supports the delivery and installation of Miltenyi Biotec's CliniMACS Prodigy cell processing system, MACSQuant flow cytometers, and GentleMACS tissue dissociators, as well as...
- This $4,884 firm fixed price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center to Miltenyi Biotec, Inc., a global biotechnology company that provides scientific instruments, reagents, and services for biomedical research and cell therapy development. The contract is not associated with a set-aside. Under this award, Miltenyi Biotec will supply the NIH Clinical Center with proprietary CliniMACS cell isolation reagents and consumables required for Good...
- This is a federal contract awarded by the National Institutes of Health (NIH) Clinical Center to Miltenyi Biotec, Inc., a global biotechnology company that specializes in cell separation, analysis, and processing technologies. The contract award, valued at $20,493.00, is a firm fixed-price purchase order to supply Miltenyi Biotec's proprietary CliniMACS cell isolation reagents, consumables, and related services to support the NIH's cell therapy manufacturing capabilities. This single-award...
- This $142,174 firm-fixed-price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center to Miltenyi Biotec, Inc., a global biotechnology company that specializes in cell separation, analysis, and processing technologies. The contract is for the supply of CliniMACS Prodigy Essential Service Units to support the NIH Clinical Center's cell therapy manufacturing capabilities. This award is part of a larger $2.3 million indefinite delivery contract (IDC) that Miltenyi...
- This is a $312,065 firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Miltenyi Biotec, Inc., a global biotechnology company specializing in cell therapy products and instruments. The contract provides for the delivery and installation of specialized laboratory equipment such as CliniMACS Prodigy cell processing systems, MACSQuant flow cytometers, and GentleMACS tissue dissociators, as well as proprietary cell isolation reagents and...
- This contract was awarded by the National Institutes of Health (NIH) Clinical Center to Miltenyi Biotec, Inc., a global biotechnology company, to provide specialized scientific instruments, reagents, and services to support the NIH's biomedical research and cell therapy development programs. The $5,420 firm fixed-price purchase order has a period of performance through September 2023. Miltenyi Biotec holds a significant $2.3 million indefinite delivery contract (IDC) with the NIH Clinical...
- This federal contract award to Miltenyi Biotec, Inc. is for the delivery of specialized laboratory equipment, reagents, and consumables to the National Institutes of Health (NIH) Clinical Center. The $5,406.00 firm-fixed-price purchase order includes products such as the GentleMACS Tissue Dissociation Kit and GentleMACS C Tubes, provided at no additional cost to the government. The award is part of a larger $2.3 million single-award indefinite delivery contract (IDC) that Miltenyi Biotec holds...
- This is a $53,081.29 firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Miltenyi Biotec, Inc., a foreign-owned for-profit manufacturer of biotechnology products. The contract, which does not have a set-aside designation, provides for the delivery and installation of specialized laboratory equipment such as flow cytometers, cell sorters, and cell processing systems, as well as related reagents and consumables. Many of the contract's...
- This is a $3,641 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Miltenyi Biotec, Inc., a global biotechnology company that specializes in cell separation, analysis, and processing technologies. The contract does not have a set-aside designation. The award supports NIAID's biomedical research programs, particularly in areas such as cancer, immunology, and infectious diseases. Key deliverables include the supply of FDA-approved,...
- This is a $23,230 firm fixed-price purchase order contract awarded to Miltenyi Biotec, Inc., a global biotechnology company, by the National Institute on Aging, a civilian federal agency. The contract delivers specialized scientific instruments, reagents, and services to support biomedical research, cell therapy development, and clinical translation, including flow cytometers, cell sorters, tissue dissociators, automated cell separation systems, and associated consumables. Miltenyi Biotec has an...
This $3,742.63 firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center to Miltenyi Biotec, Inc., a global biotechnology company that specializes in cell separation, analysis, and processing technologies. The contract supports the delivery and installation of Miltenyi's proprietary CliniMACS cell processing system, MACSQuant flow cytometers, and GentleMACS tissue dissociators, as well as associated reagents and consumables. This award is a standalone contract and does not have a set-aside designation. The contract is part of a larger $2.3 million single-award indefinite delivery contract (IDC) that Miltenyi Biotec holds with the NIH Clinical Center, which provides for the supply of clinical-grade cell isolation reagents and consumables to support the NIH's cell therapy manufacturing capabilities through September 2024, with options to extend to 2027. This sole-source IDC leverages Miltenyi Biotec's unique position as the sole manufacturer of these specialized reagents.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 8/4/17 | |
| P00001 | Funding Only Action | ($257) | 8/4/17 |